Background illustration for clinical trials search

Paid Clinical Trials Oklahoma City

Discover 572 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Study of DONQ52 in Active Celiac Disease

for
Celiac Disease
Location: Norman OK, Wichita Falls TX, Garland TX, Waco TX,
Sponsor: Chugai Pharmaceutical

Sex: All

Age: 18 - 70+

Code: NCT07239336

Phase 2, Recruiting
Active & Responsive

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Norman OK, Wichita KS, Southlake TX, Arlington TX,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819878

Phase 3, Recruiting
Active & Responsive

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

for
Parenteral Nutrition Associated Liver Disease (PNALD),
Location: Oklahoma City OK, San Antonio TX, Houston TX,
Sponsor: Fresenius Kabi

Sex: All

Age: 0 - 17

Code: NCT06274788

Recruiting
Active & Responsive

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

for
Pulmonary Hypertension, Interstitial Lung Disease (ILD)
Location: Oklahoma City OK, Dallas TX, Springfield MO,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT06911632

Recruiting
Active & Responsive

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

for
Solid Tumor Malignancies, Brain Metastases From Solid Tumors
Location: Oklahoma City OK, Dallas TX, Houston TX, Detroit MI,
Sponsor: A2A Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06136884

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Location: Oklahoma City OK, Dallas TX, Houston TX, St Louis MO,
Sponsor: Duke University

Sex: All

Age: 21+

Code: NCT01915511

Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Fort Smith AR, Salina KS, Hays KS, Topeka KS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Oklahoma City OK, Fort Smith AR, Joplin MO,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06580314

Phase 3, Recruiting

Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers

for
Lung Cancers
Location: Oklahoma City OK
Sponsor: Everest Detection, Inc.

Sex: All

Age: 30 - 70+

Code: NCT06816121

Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: Oklahoma City OK, Springdale AR, Little Rock AR,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase 3, Recruiting

GEMINI-NSCLC: NSCLC Biomarker Study

for
Non-Small Cell Lung Cancer
Location: Oklahoma City OK, Tulsa OK, Fort Smith AR, Joplin MO,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05236114

Recruiting

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Migraine
Location: Oklahoma City OK, Yukon OK, Edmond OK, Tulsa OK,
Sponsor: TriGemX Bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07645924

Phase 3, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Oklahoma City OK, Dallas TX, Arlington TX, Tyler TX,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase 3, Recruiting

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Acute Migraine
Location: Oklahoma City OK, Yukon OK, Edmond OK, Tulsa OK,
Sponsor: TriGemX Bio, Inc.

Sex: All

Age: 18+

Code: NCT07674654

Phase 3, Recruiting

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

for
Peripheral Artery Disease (PAD)
Location: Oklahoma City OK, Plano TX, DeSoto TX, Amarillo TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318610

Phase 3, Recruiting

Prospective Study to Assess a Diagnostic Aid for Cancer

for
Cancer
Location: Oklahoma City OK, Hutchinson KS, Kansas City MO,
Sponsor: Harbinger Health

Sex: All

Age: 45+

Code: NCT07046260

Recruiting

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

for
Cancer Weight Loss
Location: Oklahoma City OK, Wichita KS, Lincoln NE, Kingwood TX,
Sponsor: Endevica Bio

Sex: All

Age: 18+

Code: NCT06937177

Phase 2, Recruiting

Analgesic Comparison of PENG/LFCN to FICB for Total Hip Arthroplasty

for
Analgesia
Location: Oklahoma City OK
Sponsor: SSM Health Bone and Joint Hospital at St Anthony

Sex: All

Age: 40 - 70+

Code: NCT05477641

Recruiting

A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

for
Pneumococcal Disease
Location: Oklahoma City OK, Plano TX, Shreveport LA, Lincoln NE,
Sponsor: Pfizer

Sex: All

Age: 0

Code: NCT07573462

Phase 3, Recruiting

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: Oklahoma City OK, San Antonio TX, Houston TX,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06752681

Phase 1, Recruiting